Joseph Thome
Stock Analyst at TD Cowen
(4.86)
# 367
Out of 4,974 analysts
426
Total ratings
54.7%
Success rate
24%
Average return
Main Sectors:
Stocks Rated by Joseph Thome
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NTLA Intellia Therapeutics | Reiterated: Buy | n/a | $11.36 | - | 22 | Sep 4, 2026 | |
| QURE uniQure | Reiterated: Buy | n/a | $43.10 | - | 28 | Sep 2, 2026 | |
| UTHR United Therapeutics | Reiterated: Buy | $675 | $500.35 | +34.91% | 32 | Sep 2, 2026 | |
| JAZZ Jazz Pharmaceuticals | Reiterated: Buy | $300 | $240.83 | +24.57% | 31 | Aug 31, 2026 | |
| ARWR Arrowhead Pharmaceuticals | Reiterated: Buy | n/a | $70.67 | - | 9 | Aug 30, 2026 | |
| PTCT PTC Therapeutics | Reiterated: Buy | $90 | $65.65 | +37.09% | 48 | Aug 30, 2026 | |
| ANAB AnaptysBio | Rated: Buy | n/a | $54.68 | - | 25 | Aug 25, 2026 | |
| AMLX Amylyx Pharmaceuticals | Reiterated: Buy | n/a | $33.15 | - | 8 | Aug 18, 2026 | |
| DRUG Bright Minds Biosciences | Reiterated: Buy | n/a | $60.22 | - | 9 | Aug 16, 2026 | |
| NGEN NervGen Pharma | Reiterated: Buy | n/a | $2.14 | - | 2 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.16 | - | 13 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $300 → $315 | $204.07 | +54.36% | 35 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $140 | $93.90 | +49.09% | 10 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $10 | $3.40 | +194.12% | 22 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $20.38 | - | 5 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $21.83 | - | 17 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $56.28 | - | 17 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $57 → $58 | $46.03 | +26.00% | 21 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $17.90 | - | 2 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $42.62 | - | 16 | Jul 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $12.08 | - | 2 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $3.14 | - | 10 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $6.88 | - | 15 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $4.60 | - | 10 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $17.38 | n/a | 9 | Jul 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.000001 | n/a | 5 | Oct 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $40 | $132.75 | n/a | 1 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $11.62 | n/a | 1 | Oct 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $151.22 | n/a | 1 | Oct 1, 2020 |
Intellia Therapeutics
Sep 4, 2026
Reiterated: Buy
Price Target: n/a
Current: $11.36
Upside: -
uniQure
Sep 2, 2026
Reiterated: Buy
Price Target: n/a
Current: $43.10
Upside: -
United Therapeutics
Sep 2, 2026
Reiterated: Buy
Price Target: $675
Current: $500.35
Upside: +34.91%
Jazz Pharmaceuticals
Aug 31, 2026
Reiterated: Buy
Price Target: $300
Current: $240.83
Upside: +24.57%
Arrowhead Pharmaceuticals
Aug 30, 2026
Reiterated: Buy
Price Target: n/a
Current: $70.67
Upside: -
PTC Therapeutics
Aug 30, 2026
Reiterated: Buy
Price Target: $90
Current: $65.65
Upside: +37.09%
AnaptysBio
Aug 25, 2026
Rated: Buy
Price Target: n/a
Current: $54.68
Upside: -
Amylyx Pharmaceuticals
Aug 18, 2026
Reiterated: Buy
Price Target: n/a
Current: $33.15
Upside: -
Bright Minds Biosciences
Aug 16, 2026
Reiterated: Buy
Price Target: n/a
Current: $60.22
Upside: -
NervGen Pharma
Aug 13, 2026
Reiterated: Buy
Price Target: n/a
Current: $2.14
Upside: -
Aug 11, 2026
Reiterated: Buy
Price Target: n/a
Current: $1.16
Upside: -
Aug 10, 2026
Reiterated: Buy
Price Target: $300 → $315
Current: $204.07
Upside: +54.36%
Aug 10, 2026
Reiterated: Buy
Price Target: $140
Current: $93.90
Upside: +49.09%
Aug 6, 2026
Reiterated: Buy
Price Target: $13 → $10
Current: $3.40
Upside: +194.12%
Aug 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $20.38
Upside: -
Aug 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $21.83
Upside: -
Aug 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $56.28
Upside: -
Jul 28, 2026
Reiterated: Buy
Price Target: $57 → $58
Current: $46.03
Upside: +26.00%
Jul 28, 2026
Reiterated: Buy
Price Target: n/a
Current: $17.90
Upside: -
Jul 17, 2026
Reiterated: Buy
Price Target: n/a
Current: $42.62
Upside: -
May 14, 2026
Reiterated: Buy
Price Target: n/a
Current: $12.08
Upside: -
May 7, 2026
Reiterated: Buy
Price Target: n/a
Current: $3.14
Upside: -
May 7, 2026
Reiterated: Buy
Price Target: n/a
Current: $6.88
Upside: -
Nov 5, 2025
Reiterated: Buy
Price Target: n/a
Current: $4.60
Upside: -
Jul 19, 2024
Rated: Hold
Price Target: n/a
Current: $17.38
Upside: n/a
Oct 17, 2023
Downgraded: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
May 24, 2023
Reiterated: Hold
Price Target: $40
Current: $132.75
Upside: n/a
Oct 10, 2022
Initiated Coverage: Buy
Price Target: n/a
Current: $11.62
Upside: n/a
Oct 1, 2020
Reiterated: Buy
Price Target: n/a
Current: $151.22
Upside: n/a